By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

XBiotech USA, Inc. 

8201 E Riverside Drive
Building 4, Suite 100
Austin  Texas  78744  U.S.A.
Phone: 512-386-5107 Fax: n/a


SEARCH JOBS



Segment
Start Up





Company News
XBiotech USA (XBIT) Conducts Investigators Meeting To Update The Status Of Its Phase III Registration Study Underway In Europe 7/1/2015 7:12:52 AM
XBiotech USA (XBIT) Announces Publication Of Phase II Clinical Results For Its True Human Antibody Mabp1 For Treating Acne Vulgaris 6/15/2015 9:02:34 AM
XBiotech USA (XBIT) Appoints Kelly R. Thornburg As Senior Vice President Of Operations 6/8/2015 8:03:43 AM
XBiotech Launching Phase I/II Clinical Study Of Novel True Human Therapeutic Antibody For Treating Serious Infections Due To Staphylococcus Aureus 5/28/2015 6:42:43 AM
XBiotech USA (XBIT) Successfully Clones First Anti-Ebola Therapeutic Antibody Product Candidate 5/27/2015 7:08:36 AM
XBiotech USA (XBIT) Secures Approval From Data Safety Monitoring Board To Continue Phase III Registration Study In Europe For Its Novel Cancer Immunotherapy 5/18/2015 7:38:39 AM
XBiotech USA (XBIT) Enrolls First Patient Under Revised Protocol For U.S. Phase III Registration Study Using Xilonix For Treatment Of Metastatic Colorectal Cancer 4/29/2015 7:25:35 AM
XBiotech USA (XBIT) Closes IPO 4/17/2015 2:47:10 PM
XBiotech USA, Inc. Announces Pricing Of Initial Public Offering 4/15/2015 3:37:50 PM
XBiotech USA, Inc. Announces Phase II Psoriasis Study Results in JAMA Dermatology 3/5/2015 6:51:18 AM
123
//-->